SPECT Molecular Imaging in Atypical Parkinsonism

Area of Science:

• Neurology
• Neuroimaging
• Movement Disorders

Background:

• Atypical parkinsonism is a common cause of hypokinetic movement disorders, often misdiagnosed due to symptom overlap with Parkinson's disease.
• Patients exhibit bradykinesia, rigidity, and varied non-motor/motor symptoms like oculomotor issues and autonomic dysfunction.
• Diagnostic challenges arise from clinical heterogeneity and gradual symptom onset, hindering timely and effective treatment.

Purpose of the Study:

• To review the utility of single photon emission computed tomography (SPECT) in the differential diagnosis of atypical parkinsonism.
• To highlight SPECT's role in distinguishing atypical parkinsonism from other parkinsonian syndromes.
• To provide clinicians with insights into leveraging neuroimaging for accurate diagnosis.

Main Methods:

• Review of literature on SPECT imaging in atypical parkinsonism.
• Analysis of diagnostic contributions of SPECT in differentiating various parkinsonian syndromes.
• Focus on specific SPECT findings associated with different atypical parkinsonism subtypes.

Main Results:

• SPECT imaging demonstrates characteristic patterns that assist in differentiating atypical parkinsonism from idiopathic Parkinson's disease.
• Specific radiotracers and imaging protocols can reveal distinct neurochemical deficits in various atypical parkinsonism conditions.
• SPECT findings correlate with clinical presentations, aiding in early and accurate diagnosis.

Conclusions:

• Single photon emission computed tomography (SPECT) is a valuable tool for the differential diagnosis of atypical parkinsonism.
• SPECT imaging improves diagnostic accuracy, enabling earlier and more appropriate patient management.
• Neuroimaging, particularly SPECT, plays a crucial role in understanding and diagnosing complex movement disorders.